Translating science into innovative diagnostic solutions
Developing solutions for important global health issues
Quadrant Biosciences works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications.
Our evolutionary advancements in brain health assessment, autism and Parkinson’s detection, will have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions going forward. Supported through private and state funding, one of these key technologies, ClearEdge, is currently available in the market. In addition, our groundbreaking autism diagnostic aid, Clarifi ASD, is slated for a 2019 release.
Quadrant Biosciences in the News!
Quadrant Biosciences Recognized as New York Technology Business of the Year
Quadrant Biosciences Inc. has been awarded the Technology Business of the Year by the New York State Small Business Development Center (SBDC).
A Review of MicroRNA Biomarkers in Traumatic Brain Injury
Read about our groundbreaking research and emerging evidence suggesting that microRNAs (miRNAs) may provide information about the injured brain.
Quadrant Biosciences is pleased to have been selected as a StartupNY company.